Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Document › Details

Arsanis, Inc.. (3/9/18). "Press Release: Arsanis Reports Financial Results and Highlights for Fourth Quarter and Full Year 2017". Waltham, MA & Vienna.

Organisations Organisation Arsanis Inc. (Nasdaq: ASNS)
  Group Arsanis (Group)
  Organisation 2 Bill and Melinda Gates Foundation
Products Product ASN100 (Arsanis)
  Product 2 ASN500 (Arsanis)
Index term Index term Arsanis–SEVERAL: investment, 201711 IPO $46m with 4m+600k shares common stock at $10/share at Nasdaq Global Market
Persons Person Russo, René (Arsanis 201702 CEO)
  Person 2 Gibbs, Krystle (Ten Bridge Communications 201703)
     


   
Record changed: 2018-03-22

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

More documents for Arsanis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translationl Medicine 2018 Würzburg Germany 600x100px




» top